1
Clinical Trials associated with GAP3KO vaccine(SCRI)Trial to Assess the Safety, Attenuation and Immunogenicity of Genetically-attenuated p52-/p36-/sap1- Plasmodium Falciparum Parasites (GAP3KO) Administered Via Infected Anopheles Stephensi Mosquitoes to Malaria-Naïve Adults
Study designed to evaluate safety and tolerability of a genetically attenuated P. falciparum (GAP3KO) that arrests early in the liver stage of the parasite life cycle. Study will also confirm the attenuation of the GAP3KO parasites using peripheral blood smears. Secondary objectives are to evaluate the humoral immune responses to GAP3KO.
100 Clinical Results associated with GAP3KO vaccine(SCRI)
100 Translational Medicine associated with GAP3KO vaccine(SCRI)
100 Patents (Medical) associated with GAP3KO vaccine(SCRI)
100 Deals associated with GAP3KO vaccine(SCRI)